Learn from leading experts and hear personal stories from others that have been there.

Visit our YouTube channel to see all our videos. While you’re there, subscribe to be notified when new videos are added.


BeACTive: Empowering workouts for people with breast cancer

This new, 3-week exercise series features 9 workouts of about 20 minutes each and is designed especially for people who are going through or recovering from treatment, preparing for surgeries, or regaining mobility after surgery. See the full playlist.

Filter Filters icon

ESR1 testing: What you need to know


If you have been diagnosed with estrogen receptor-positive, HER2-negative metastatic breast cancer you may develop an ESR1 mutation after progression on endocrine therapy. ESR1 mutation testing can help you and your healthcare team make decisions about the most effective treatment options for you. Eleonora Teplinksy, MD explains more about more about this test, who should get tested and when, and how it impacts treatments for metastatic breast cancer.

Monica’s story: Regaining control after breast cancer with exercise


A diagnosis of estrogen-positive breast cancer at 54 reshaped Monica’s perspective, making exercise about movement and regaining control of her life. Recently, she’s been trying something new that fosters a shared experience with others who have been impacted by breast cancer. Meet all of the women in our BeACTive series.

Ask the expert: Early-stage hormone receptor-positive, HER2-positive & triple-positive breast cancer


Understanding your breast cancer diagnosis, treatment, and potential side effects can be overwhelming. In this video, Reshma L. Mahtani, DO, answers questions about breast cancer treatment options, recent drug approvals, immunotherapy, as well as symptoms and side effects for early stage hormone receptor-positive, HER2-positive, and triple-positive breast cancer.

Ask the expert: Hormone receptor-positive breast cancer


In this video, Oncologist Sameer Gupta, MD, MPH, shares information about the importance of hormone receptor status in getting the right treatment, explains the complexities of HR-targeting therapies, and shares the newest treatment options. Dr. Gupta then answers questions regarding both early-stage and metastatic hormone receptor-positive breast cancer.